Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Capricor Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +14 vs. Q4 2024
- Shares held
- 18.3M
- +1.17M (+6.8%) vs. Q4 2024
- Total value
- $174.0M
- −$62.8M (−26.5%) vs. Q4 2024
- New holders
- 33
- 46 more added
- Sold out
- 19
- 24 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CAPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 169 | $941.6M |
| Q1 2026 | 177 | $1.03B |
| Q4 2025 | 132 | $790.7M |
| Q3 2025 | 115 | $104.1M |
| Q2 2025 | 108 | $136.5M |
| Q1 2025 | 121 | $174.0M |
| Q4 2024 | 108 | $239.1M |
| Q3 2024 | 75 | $127.3M |
| Q2 2024 | 61 | $30.7M |
| Q1 2024 | 56 | $32.7M |
| Q4 2023 | 37 | $19.7M |
| Q3 2023 | 34 | $18.9M |
| Q2 2023 | 32 | $12.5M |
| Q1 2023 | 30 | $10.3M |
| Q4 2022 | 31 | $10.6M |
| Q3 2022 | 31 | $16.8M |
| Q2 2022 | 29 | $8.87M |
| Q1 2022 | 29 | $8.88M |
| Q4 2021 | 25 | $6.80M |
| Q3 2021 | 30 | $10.0M |
| Q2 2021 | 31 | $18.1M |
| Q1 2021 | 30 | $20.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Capricor Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PFM Health Sciences, LP | 140,681 | $1.34M | 0.10% | +86,324+158.8% | Added |
| Kennedy Capital Management, Inc. | 153,487 | $1.46M | 0.03% | +9,237+6.4% | Added |
| Jump Financial, LLC | 163,021 | $1.55M | 0.02% | +163,021 | New |
| Susquehanna International Group, LLP | 168,988 | $1.60M | 0.00% | −112,314−39.9% | Reduced |
| Squarepoint Ops LLC | 171,213 | $1.62M | 0.00% | +144,226+534.4% | Added |
| Millennium Management LLC | 222,070 | $2.11M | 0.00% | +106,428+92.0% | Added |
| Avidity Partners Management LP | 239,000 | $2.27M | 0.47% | +239,000 | New |
| Superstring Capital Management LP | 241,192 | $2.29M | 2.73% | +185,963+336.7% | Added |
| Black Diamond Financial, LLC | 277,737 | $2.64M | 0.40% | 00.0% | Unchanged |
| Pier Capital, LLC | 354,181 | $3.36M | 0.56% | +354,181 | New |
| Northern Trust Corp | 379,773 | $3.60M | 0.00% | −4,384−1.1% | Reduced |
| UBS Group AG | 393,343 | $3.73M | 0.00% | +270,525+220.3% | Added |
| Goldman Sachs Group Inc | 411,141 | $3.90M | 0.00% | +116,373+39.5% | Added |
| Citadel Advisors LLC | 415,951 | $3.95M | 0.00% | +150,709+56.8% | Added |
| Woodline Partners LP | 729,318 | $6.92M | 0.05% | +99,384+15.8% | Added |
| Morgan Stanley | 815,365 | $7.74M | 0.00% | +183,611+29.1% | Added |
| Geode Capital Management, LLC | 901,379 | $8.56M | 0.00% | +21,911+2.5% | Added |
| State Street Corp | 1,842,800 | $17.5M | 0.00% | −365,568−16.6% | Reduced |
| Farallon Capital Management, L.L.C. | 2,250,400 | $21.4M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,263,991 | $21.5M | 0.00% | −12,793−0.6% | Reduced |
| BlackRock, Inc. | 2,944,665 | $27.9M | 0.00% | −22,249−0.7% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −714,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −104,798−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −103,734−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −59,303−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −56,120−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −53,734−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −22,920−100.0% | Sold out |
| Bryce Point Capital, LLC | 0 | $0 | 0.00% | −22,709−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −18,243−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,097−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,317−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −4,957−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |